
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.130 | 0.130 | 0.000 |
Shares | 99.870 | 99.870 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 13.540 | 14.566 |
Price to Book | 2.839 | 2.258 |
Price to Sales | 1.311 | 1.337 |
Price to Cash Flow | 10.804 | 9.602 |
Dividend Yield | 2.827 | 2.449 |
5 Years Earnings Growth | 10.563 | 9.891 |
Name | Net % | Category Average |
---|---|---|
Technology | 21.510 | 14.840 |
Healthcare | 21.330 | 17.157 |
Consumer Cyclical | 19.230 | 7.627 |
Consumer Defensive | 15.420 | 8.725 |
Industrials | 12.510 | 10.144 |
Basic Materials | 4.620 | 3.948 |
Communication Services | 2.690 | 6.749 |
Energy | 2.680 | 7.280 |
Number of long holdings: 41
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Darden Restaurants Inc | - | 2.96 | - | - | |
Eli Lilly and Co | - | 2.94 | - | - | |
CA Inc | - | 2.81 | - | - | |
Pfizer Inc | - | 2.79 | - | - | |
Johnson Controls | IE00BY7QL619 | 2.69 | 103.35 | +1.08% | |
Comcast Corp Class A | - | 2.69 | - | - | |
Walmart Inc | - | 2.69 | - | - | |
Bristol-Myers Squibb Company | - | 2.68 | - | - | |
Marathon Petroleum Corp | - | 2.67 | - | - | |
Target Corp | - | 2.67 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DeutscheInv I GlblInfra USD LC | 2.37B | 11.06 | 2.93 | 4.77 | ||
Deutsche Invest I Top Dividend USDl | 2.29B | 14.22 | 5.30 | 4.92 | ||
Deutsche Invest I Top Dividend USDf | 2.29B | 14.58 | 6.09 | 5.69 | ||
DeutscheInv I GlblInfra USD ID | 2.37B | 11.05 | 1.34 | - | ||
DeutscheInv I GlblInfra USD LD | 2.37B | 10.03 | 0.40 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review